The new TrumpRx program relies partly on connecting consumers with discount coupons offered by drugmakers. For insured patients, though, using a coupon can prove dicey.
Congressional Democrats are investigating clemency recipients who may have obtained favorable treatment from Trump or his advisers "through intermediaries, financial contributions, or other forms of influence."
